Shane Gleason
Corporate Officer/Principal at INSPIREMD, INC.
Net worth: 985 009 $ as of 29/04/2024
Profile
Shane Gleason is currently the Chief Commercial Officer at InspireMD, Inc. Prior to his current position, he held the role of Senior Director at Edwards Lifesciences Corp.
from 2019 to 2021.
From 2015 to 2017, he served as the Vice President-Sales at Cordis Corp.
In 2021 to 2023, he was the Vice President-Sales at Surmodics, Inc. He also served as the Chief Commercial Officer at Nuvaira, Inc. from 2017 to 2019.
Mr. Gleason obtained his undergraduate degree from Virginia Polytechnic Institute & State University and holds an MBA from The Stephen J.R.
Smith School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSPIREMD, INC.
2.20% | 17/04/2024 | 514,365 ( 2.20% ) | 985 009 $ | 29/04/2024 |
Shane Gleason active positions
| Companies | Position | Start |
|---|---|---|
| INSPIREMD, INC. | Corporate Officer/Principal | 02/10/2023 |
Former positions of Shane Gleason
| Companies | Position | End |
|---|---|---|
| SURMODICS, INC. | Sales & Marketing | 31/01/2023 |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | 31/05/2021 |
Nuvaira, Inc.
 Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Corporate Officer/Principal | 30/06/2019 |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Sales & Marketing | 31/03/2017 |
Training of Shane Gleason
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| The Stephen J.R. Smith School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| INSPIREMD, INC. | Health Technology |
| SURMODICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Nuvaira, Inc.
Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Electronic Technology |
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
- Stock Market
- Insiders
- Shane Gleason
